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V
irtually all cells and organisms 
require iron to perform 
basic cellular processes. In 
respiration, iron proteins capture 
energy released from oxidation of 
food by synthesizing high-energy 
compounds, such as NADH, that 
are used to fuel cellular metabolism. 
Iron also enables hemoglobin in red 
blood cells to bind and transport 
oxygen to tissues throughout the 
body. Since iron is indispensable for 
respiration and oxygen transport, it is 
not surprising that cellular acquisition 
of iron has not been left to chance. It 
can be a challenge for organisms to 
obtain sufficient iron because much 
environmental iron is very insoluble. 
Thus, elaborate systems for uptake of 
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iron and distribution within organisms 
are found throughout the kingdoms 
of life (reviewed in Lippard and Berg 
1994).
 Iron deficiency has been a common 
affliction throughout human history, 
and it is now estimated to affect 1 
billion people worldwide (Baynes 
and Cook 1996). The characteristic 
syndrome of pallor, weakness, shortness 
of breath, and swelling was initially 
described by the ancient Egyptians, but 
it was not until the 20th century that 
doctors learned that these symptoms 
were caused by iron deficiency 
(Fairbanks and Beutler 1995). In 
mammals, dietary iron is absorbed 
from digestion of food in the duodenal 
portion of the gut. Specific iron 
transporters are present in epithelial 
cells that line the duodenum, and these 
transporters are much more abundant 
in iron-deficient animals. Mammals—
including humans—have the ability 
to communicate their iron needs to 
the duodenum (Anderson et al. 2002; 
Andrews 2002). 
In part because of iron’s relevance 
to human disease, the molecular 
mechanisms by which mammals 
register their need for iron and activate 
responses that will restore iron balance 
are the subject of much ongoing study. 
Abnormal regulation of iron uptake 
is the cause of the common human 
disease hemochromatosis, in which 
excessive iron uptake eventually leads 
to iron overload and disease of the liver, 
heart, and other organs (Anderson and 
Powell 2002; Ajioka and Kushner 2003). 
Once iron has crossed the barrier 
cells of the duodenum, it is released 
into blood and is circulated to tissues 
throughout the body. However, 
it is not practical to circulate free 
elemental iron because iron can bind 
indiscriminately to many proteins. 
Therefore, iron is transported in an 
unreactive form by a specific carrier 
protein, transferrin (Baker et al. 2003). 
Most of the iron that gains access to the 
circulating blood binds tightly to serum 
transferrin, an abundant protein that 
binds one (monoferric) or two ferric 
iron atoms (diferric or holotransferrin) 
with high affinity. When ferric iron is 
bound to transferrin, it is nonreactive, 
meaning that it does not engage in 
single-electron transfers and it does 
not threaten other proteins and blood 
vessel walls with its reactivity. Also, 
because transferrin is a large protein, 
it remains in the circulation instead 
of being lost in urine when it passes 
through the kidney. Thus, cells and 
tissues that need to replenish their iron 
stores can do so by taking up transferrin 
that contains bound iron. Cells 
accomplish this task by synthesizing 
transferrin receptors, proteins that are 
present as pairs (dimers) on the cell 
surface. Membranes of iron-starved 
cells contain many more transferrin 
receptors than those of iron-replete 
cells, indicating that cells can appraise 
their own iron needs and increase 
transferrin receptor synthesis when they 
are iron-starved (Aisen 1994). 
When holotransferrin binds to the 
transferrin receptor, the complex 
of transferrin bound to the receptor 
is internalized by a process known 
as clathrin-mediated endocytosis, 
a mechanism for moving the 
surface receptor complexes into 
discrete membrane-bound physical 
environments within cells known as 
endosomal vesicles (Mousavi et al. 
2003). These endosomes are then 
acidified by vesicular membrane 
proteins that pump protons, and iron 
is released from transferrin upon 
vesicular acidification. The transferrin 
that now lacks iron (apotransferrin) 
remains bound to the transferrin 
receptor, and this complex recycles to 
the cell surface, where apotransferrin 
dissociates from the transferrin 
receptor upon exposure to normal pH. 
The iron that was released within the 
acidified endosome is then transported 
across the vesicular membrane into the 
cytoplasm, where it is used to meet the 
nutritional needs of the cell (reviewed 
in Klausner et al. 1993). 
In the inherited human disease 
hemochromatosis, researchers spent 
many years trying to identify the 
genetic abnormality responsible for 
iron overload. In 1996, after several 
decades of searching, the main gene 
that causes genetic hemochromatosis 
was identified (Feder et al. 1996). 
Much to the surprise of investigators, 
this gene, known as HFE, proved 
to be related to a group of proteins 
important in immunology, known 
as major histocompatibility complex 
antigens. More surprising still was the 
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Figure 1. Binding of Transferrin 
Transferrin (purple rhombus) binds two ferric iron atoms (orange squares) and 
circulates in the bloodstream until it comes into contact with transferrin receptors, which 
pair together to form dimers (red torpedo shapes) on the plasma membrane surface of 
cells. A complex of HFE (blue square) and 2-microglobulin (green square) binds to the 
transferrin receptor. Notably, the binding site for HFE overlaps the potential binding 
site of transferrin. Since it is likely that HFE associates with transferrin receptors shortly 
after synthesis, before the complex arrives at the plasma membrane, HFE can thus 
potentially prevent iron uptake through the transferrin receptor. Once transferrin binds 
the transferrin receptor (assuming that both potential binding sites are not blocked by 
HFE), the complex internalizes in an endosome, where acidification promotes release 
of ferric iron, and reduction by addition of an electron (e–) to ferrous or diferric iron 
allows transport of free iron from the endosome, using the divalent metal transporter, 
DMT1, to the cytosol. Upon release into the cytosol, iron can be incorporated into 
proteins, and its presence can be sensed by iron regulatory proteins (IRPs).Volume 1  |  Issue 3  |  Page 328 PLoS Biology  |  http://biology.plosjournals.org
discovery that HFE binds to transferrin 
receptor dimers (Feder et al. 1998). 
When proteins bind to one another 
in cells, it is usually because they 
are collaborating to accomplish an 
important task. However, in the case of 
the transferrin receptor–HFE complex, 
it remains unclear how HFE contributes 
to transferrin receptor function and 
iron metabolism. 
Often in biology, information about 
the shape of protein complexes and 
their location in cells can facilitate 
insights into mechanisms of protein 
function. Previously, the structure of 
the transferrin receptor dimer bound 
to HFE and a smaller molecule known 
as 2-microglobulin has been described 
in great detail (Lebrón et al. 1998; 
Bennett et al. 2000). However, though 
the structures of various transferrins 
alone have been obtained, attempts to 
obtain structural information about 
the transferrin–transferrin receptor 
complex have been unsuccessful. When 
the individual structures of proteins 
that bind to one another are known, 
as is the case for transferrin and the 
transferrin receptor, educated guesses 
about amino acid contact points 
between proteins can be evaluated by 
substituting various amino acids in 
each protein to see whether binding is 
affected. 
In an article in this issue of PLoS 
Biology by Giannetti et al. (2003), the 
authors have substituted specific amino 
acids in the transferrin receptor with 
different amino acids to determine 
whether they are important in binding 
either HFE or diferric transferrin. 
They have reached an interesting 
conclusion: their data indicate that 
diferric transferrin and HFE bind to 
physically and functionally overlapping 
sites on the transferrin receptor (West 
et al. 2001). A logical extension of this 
conclusion is that if each monomer 
in the transferrin receptor dimer 
were bound to HFE, the transferrin 
receptor would not be able to bind 
and internalize diferric transferrin. 
Thus, it would be very interesting to 
know how many transferrin receptor 
complexes contain HFE and whether 
there are situations when there are 
two HFE molecules bound to each 
transferrin receptor dimer. If HFE has 
the potential to prevent binding of 
transferrin, which is the reason that 
the transferrin receptor exists in the 
first place, why is HFE present at all? 
Is it possible that HFE plays a role in 
vesicular trafficking? Does the HFE 
protein contain information that allows 
the iron-loaded vesicle to interact with 
specific proteins or compartments that 
will efficiently monitor iron influx and 
appropriately distribute the iron within 
the cell? Is HFE synthesized to prevent 
iron uptake through the transferrin 
receptor under special circumstances? 
Many additional studies using imaging 
and biochemical techniques will be 
needed to address the role of HFE. 
Structural information can also help 
to model how iron is released from 
the transferrin–transferrin receptor 
complex within acidified endosomes. 
Giannetti et al. (2003) suggest that 
several of the amino acids to which 
holotransferrin is bound at neutral pH 
cease to act as tight binding sites once 
they undergo protonation at acidic 
pH. The holotransferrin then is free 
to move about and adopt different 
binding conformations, some of 
which favor the release of iron from 
transferrin within the endosome. 
This arrangement ensures that iron is 
released only when it is in an enclosed 
vesicle that is designed to handle the 
free iron. 
Once the iron is exported from the 
endosome, little is known about how 
it is transported and made available 
to proteins in the cell that require 
iron incorporation to function. 
Several cytosolic proteins, known as 
iron regulatory proteins (IRPs), are 
responsible for monitoring cytosolic 
iron levels and regulating iron 
availability. When iron supplies are 
low, IRPs increase transferrin receptor 
expression and thereby help the cell 
to restore iron balance (reviewed in 
Rouault and Klausner 1997; Schneider 
and Leibold 2000). 
Thus, transferrin and the transferrin 
receptor are proteins that play central 
roles in mammalian iron metabolism. 
Transferrin solves the problem of 
how to move iron through the body 
safely and efficiently. Similarly, the 
transferrin receptor protects cells from 
indiscriminate and potentially harmful 
iron uptake. The transferrin receptor 
is present on the surface of only those 
cells that need iron, because cells 
regulate how much transferrin receptor 
they make according to their needs. 
Clearly, HFE binding will be important 
in transferrin receptor function, but we 
do not yet understand how it functions. 
However, all future models will need 
to account for the fact that the binding 
site of HFE on the transferrin receptor 
overlaps with the binding site of 
transferrin. The fact that we cannot 
yet offer a good reason for this design 
reveals that there is much more work 
to do on the relationship between 
transferrin receptors and HFE. 
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